Advanced glycation end products induce moesin phosphorylation in murine retinal endothelium

Acta Diabetologica

Volumn 49, Issue 1, 2012, Pages 47-55

  Wang, Lingjun ^a   Li, Qiaoqin ^a   Du, Jing ^a   Chen, Bo ^a   Li, Qiang ^a   Huang, Xuliang ^a   Guo, Xiaohua ^a   Huang, Qiaobing ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Advanced glycation end products; Blood retinal barrier; Moesin; p38MAPK; ROCK

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ADVANCED GLYCATION END PRODUCT; F ACTIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; MOESIN; RHO KINASE; ACTIN BINDING PROTEIN; PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD RETINA BARRIER; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; GENE; GENE EXPRESSION PROFILING; IMMUNOHISTOCHEMISTRY; MOESIN GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITION; RETINA BLOOD VESSEL; RETINA DISEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CAPILLARY PERMEABILITY; DRUG EFFECT; ENDOTHELIUM CELL; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; RETINA;

ANIMALS; CAPILLARY PERMEABILITY; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; MICE; MICE, INBRED C57BL; MICROFILAMENT PROTEINS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN KINASES; RETINA; RETINAL VESSELS; RHO-ASSOCIATED KINASES;

EID: 84861692366     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-011-0267-z     Document Type: Article

References (36)

1. Williams R, Airey M, Baxter H, Forrester J, Kennedy-Martin T, Girach A (2004) Epidemiology of diabetic retinopathy and macular oedema: a systematic review. Eye 18:963-983 (Pubitemid 39430033)
2. Bloomgarden ZT (2007) Screening for and managing diabetic retinopathy: current approaches. Am J Health Syst Pharm 64:S8-S14
3. King GL (2008) The role of inflammatory cytokines in diabetes and its complications. J Periodontol 79:1527-1534
4. Menghini R, Casagrande V, Cardellini M, Martelli E, Terrinoni A, Amati F, Vasa-Nicotera M, Ippoliti A, Novelli G, Melino G, Lauro R, Federici M (2009) MicroRNA 217 modulates endothelial cell senescence via silent information regulator 1. Circulation 120:1524-1532
5. Sander B, Hamann P, Larsen M (2008) A 5-year follow-up of photocoagulation in diabetic macular edema: the prognostic value of vascular leakage for visual loss. Graefes Arch Clin Exp Ophthalmol 246:1535-1539
6. Pfister F, Wang Y, Schreiter K, vom Hagen F, Altvater K, Hoffmann S, Deutsch U, Hammes HP, Feng Y (2010) Retinal overexpression of angiopoietin-2 mimics diabetic retinopathy and enhances vascular damages in hyperglycemia. Acta Diabetol 47:59-64
7. Tarallo S, Beltramo E, Berrone E, Dentelli P, Porta M (2010) Effects of high glucose and thiamine on the balance between matrix metalloproteinases and their tissue inhibitors in vascular cells. Acta Diabetol 47:105-111
8. Cardellini M, Menghini R, Martelli E, Casagrande V, Marino A, Rizza S, Porzio O, Mauriello A, Solini A, Ippoliti A, Lauro R, Folli F, Federici M (2009) TIMP3 is reduced in atherosclerotic plaques from subjects with type 2 diabetes and increased by SirT1. Diabetes 58:2396-2401
9. Yamagishi S, Ueda S, Matsui T, Nakamura K, Okuda S (2008) Role of advanced glycation end products (AGEs) and oxidative stress in diabetic retinopathy. Curr Pharm Des 14:962-968 (Pubitemid 351753283)
10. Federici M, Lauro R (2005) Review article: diabetes and atherosclerosis-running on a common road. Aliment Pharmacol Ther 22 (Suppl 2):11-15 (Pubitemid 41564374)
11. Barile GR, Schmidt AM (2007) RAGE and its ligands in retinal disease. Curr Mol Med 7:758-765
12. Naka Y, Bucciarelli LG, Wendt T, Lee LK, Rong LL, Ramasamy R, Yan SF, Schmidt AM (2004) RAGE axis: animal models and novel insights into the vascular complications of diabetes. Arterioscler Thromb Vasc Biol 24:1342-1349 (Pubitemid 39050425)
13. Guo XH, Huang QB, Chen B, Wang ShY, Hou FF, Fu N (2005) Mechanism of advanced glycation end products-induced hyperpermeability in endothelial cells. Acta Physiol Sino 57:205-210
14. Wang ZhH, Guo XH, Liu XL, Li Q, Wang JP, Wang LJ, Huang QB (2008) The morphological changes of vascular endothelial cadherin in human umbilical vein endothelial cells induced by advanced glycation end products. Chin J Arterioscler 16:505-509
15. Guo XH, Wang LJ, Chen B, Li Q, Wang J, Zhao M, Wu W, Zhu P, Huang X, Huang Q (2009) ERM protein moesin is phosphorylated by advanced glycation end products and modulate vascular permeability. Am J Physiol Heart Circ Physiol 297:H238-H246
16. Wang JP, Guo XH, Wang LJ, Li Q, Chen B, Wu W, Huang X, Huang Q (2009) Effects of Rho/Rock signal pathway on AGEs induced morphological and functional changes in HMVECs-1. Acta Physiol Sinica 61:132-138
17. Hou FF, Miyata T, Boyce J, Yuan Q, Chertow GM, Kay J, Schmidt AM, Owen WF (2001) Beta(2)-Microglobulin modified with advanced glycation end products delays monocyte apoptosis. Kidney Int 59:990-1002 (Pubitemid 32206862)
18. Gopalkrishnapillai B, Nadanathangam V, Karmakar N, Anand S, Misra A (2003) Evaluation of autofluorescent property of hemoglobin-advanced glycation end product as a long-term glycemic index of diabetes. Diabetes 52:1041-1046 (Pubitemid 36384276)
19. Sattarahmady N, Khodagholi F, Moosavi-Movahedi AA, Heli H, Hakimelahi GH (2007) Alginate as an antiglycating agent for human serum albumin. Int J Biol Macromol 41:180-184 (Pubitemid 46656403)
20. Stitt AW, McGoldrick C, Rice-McCaldin A, McCance DR, Glenn JV, Hsu DK, Liu FT, Thorpe SR, Gardiner TA (2005) Impaired retinal angiogenesis in diabetes: role of advanced glycation end products and galectin-3. Diabetes 54:785-794 (Pubitemid 40322083)
21. Qaum T, Xu Q, Joussen AM, Clemens MW, Qin W, Miyamoto K, Hassessian H, Wiegand SJ, Rudge J, Yancopoulos GD, Adamis AP (2001) VEGF-initiated blood-retinal barrier breakdown in early diabetes. Invest Ophthalmol Vis Sci 42:2408-2413 (Pubitemid 32848873)
22. Moore TC, Moore JE, Kaji Y (2003) The role of advanced glycation end products in retinal microvascular leukostasis. Invest Ophthalmol Vis Sci 44:4457-4464 (Pubitemid 37186283)
23. Hughes JM, Kuiper EJ, Klaassen I, Canning P, Stitt AW, Van Bezu J, Schalkwijk CG, Van Noorden CJ, Schlingemann RO (2007) Advanced glycation end products cause increased CCN family and extracellular matrix gene expression in the diabetic rodent retina. Diabetologia 50:1089-1098 (Pubitemid 46559257)
24. Yu PK, Yu DY, Cringle SJ, Su EN (2005) Endothelial F-actin cytoskeleton in the retinal vasculature of normal and diabetic rats. Curr Eye Res 30:279-290 (Pubitemid 40806649)
25. Rist RJ, Romero IA, Chan MW, Couraud PO, Roux F, Abbott NJ (1997) F-actin cytoskeleton and sucrose permeability of immortalised rat brain microvascular endothelial cell monolayers: effects of cyclic AMP and astrocytic factors. Brain Res 768:10-18 (Pubitemid 27433471)
26. Masumoto J, Sagara J, Hayama M, Hidaka E, Katsuyama T, Taniguchi S (1998) Differential expression of moesin in cells of hematopoietic lineage and lymphatic systems. Histochem Cell Biol 110:33-41 (Pubitemid 28293871)
27. Iontcheva I, Amar S, Zawawi KH, Kantarci A, Van Dyke TE (2004) Role for moesin in lipopolysaccharide-stimulated signal transduction. Infect Immun 72:2312-2320 (Pubitemid 38419947)
28. Hiroki J, Shimokawa H, Higashi M, Morikawa K, Kandabashi T, Kawamura N, Kubota T, Ichiki T, Amano M, Kaibuchi K, Takeshita A (2004) Inflammatory stimuli upregulate Rho-kinase in human coronary vascular smooth muscle cells. J Mol Cell Cardiol 37:537-546 (Pubitemid 38953381)
29. Killock DJ, Parsons M, Zarrouk M, Ameer-Beg SM, Ridley AJ, Haskard DO, Zvelebil M, Ivetic A (2009) In vitro and in vivo characterization of molecular interactions between calmodulin, Ezrin/Radixin/Moesin, and L-selectin. J Biol Chem 284:8833-8845
30. Koss M, Pfeiffer GR II, Wang Y, Thomas ST, Yerukhimovich M, Gaarde WA, Doerschuk CM, Wang Q (2006) Ezrin/radixin/moesin proteins are phosphorylated by TNF-alpha and modulate permeability increases in human pulmonary microvascular endothelial cells. J Immunol 176:1218-1227 (Pubitemid 43099726)
31. Nakamura F, Amieva MR, Furthmayr H (1995) Phosphorylation of threonine 558 in the carboxyl-terminal actin-binding domain of moesin by thrombin activation of human platelets. J Biol Chem 270:31377-31385 (Pubitemid 26012231)
32. Kaur C, Foulds WS, Ling EA (2008) Blood-retinal barrier in hypoxic ischaemic conditions: basic concepts, clinical features and management. Prog Retin Eye Res 27:622-647
33. Berryman M, Franck Z, Bretscher A (1993) Ezrin is concentrated in the apical microvilli of a wide variety of epithelial cells whereas moesin is found primarily in endothelial cells. J Cell Sci 105:1025-1043 (Pubitemid 23258665)
34. Pachydaki SI, Tari SR, Lee SE, Ma W, Tseng JJ, Sosunov AA, Cataldergirmen G, Scarmeas N, Caspersen C, Chang S, Schiff WM, Schmidt AM, Barile GR (2006) Upregulation of RAGE and its ligands in proliferative retinal disease. Exp Eye Res 82:807-815 (Pubitemid 43170881)
35. Matsui T, Maeda M, Doi Y, Yonemura S, Amano M, Kaibuchi K, Tsukita S, Tsukita S (1998) Rho-kinase phosphorylates COOH-terminal threonines of ezrin/radixin/moesin (ERM) proteins and regulates their head-to-tail association. J Cell Biol 140:647-657 (Pubitemid 28134067)
36. Lan M, Kojima T, Murata M, Osanai M, Takano K, Chiba H, Sawada N (2006) Phosphorylation of ezrin enhances microvillus length via a p38 MAP-kinase pathway in an immortalized mouse hepatic cell line. Exp Cell Res 312:111-120 (Pubitemid 41721174)